Affordable Access

deepdyve-link deepdyve-link
Publisher Website

NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.

Authors
Type
Published Article
Journal
Cancer Letters
0304-3835
Publisher
Elsevier
Publication Date
Volume
367
Issue
1
Pages
58–68
Identifiers
DOI: 10.1016/j.canlet.2015.07.007
PMID: 26188279
Source
Medline
Keywords
  • Apoptosis
  • Cell Cycle Arrest
  • Glioma
  • Nvp-Bez235
  • Pi3K–Akt–Mtor
  • Temozolomide

Abstract

Statistics

Seen <100 times